Veterinary Medicines

KOLIBIN RC NEO, Injekční emulze

Authorised
  • Bovine rotavirus, Inactivated
  • Bovine coronavirus, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9:K35, Inactivated
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
Download as PDF

Product identification

Medicine name:
KOLIBIN RC NEO, Injekční emulze
Active substance:
  • Bovine rotavirus, Inactivated
  • Bovine coronavirus, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9:K35, Inactivated
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
Target species:
  • Cattle (cow)
  • Cattle (pregnant heifer)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine rotavirus, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine coronavirus, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, serotype O9:K35, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (cow)
      • Meat
        0
        day
      • Milk
        0
        hour
    • Cattle (pregnant heifer)
      • Meat
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 97/029/05-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."